Stay Connected with ERT:
-
Recent Posts
- Improving Your Drug’s Value Proposition throughout the Product Lifecycle: How Optimized Clinical Outcomes Assessment (COA) Strategies Can Drive Commercialization Success
- Metrics Champion Consortium – Cardiopulmonary Performance Metrics Initiative
- The Importance of Inspiratory Capacity in COPD Clinical Trials
- CLEAR Study Update: A look inside the collaboration between ERT and UCLA
- Brief Report – Changes to the FDA Draft Guidance Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials
Archives
Category Archives: Suicidality Monitoring
ePRO Seminar Series: Bringing Scientific Experts Direct to Your Location.
We are pleased to announce an upcoming seminar series for ePRO beginning this September! The collection of patient self-reported data is becoming increasingly important and, in some cases, a regulatory requirement in the assessment of safety and efficacy, and to … Continue reading
ePRO Webinar Series – Prospectively Monitoring for Suicidality + Bonus Q&A Session
On April 6, 2011, ERT held a webinar on prospectively monitoring for suicidality in non-mental health indications that included guest speakers: Kelly Posner, Ph.D, Columbia University, John Greist, M.D., HTS, and Michael Federico, VP ePRO Solutions, ERT. Such an important issue drew in … Continue reading
